Related Experiment Videos
[Microvolt T wave alternans as a predictor for sudden cardiac death]
Kaoru Tanno1, Takashi Katagiri
1Third Department of Internal Medicine, Showa University, School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 26, 2002
Summary
Microvolt T wave alternans (MTWA) effectively identifies patients at risk for lethal ventricular tachyarrhythmias. This heart rate-dependent test shows high sensitivity for predicting sudden cardiac death post-myocardial infarction.
Area of Science:
- Cardiology
- Electrophysiology
Context:
- Identifying patients at risk for sudden cardiac death (SCD) is crucial for primary prevention.
- Implantable cardioverter-defibrillators (ICDs) are effective but identifying appropriate candidates remains challenging.
- Malignant ventricular tachyarrhythmias pose a significant threat, particularly after myocardial infarction or in patients with DCM or impaired cardiac function.
Purpose:
- To evaluate the utility of microvolt T wave alternans (MTWA) as a screening tool for lethal ventricular tachyarrhythmias.
- To assess the predictive value of exercise-induced MTWA for sudden cardiac death in post-myocardial infarction patients.
Summary:
- Microvolt T wave alternans (MTWA) is a promising method for identifying patients prone to lethal ventricular tachyarrhythmias.
- MTWA measurement is heart rate-dependent and can be performed during exercise, pharmacological stress, or cardiac pacing.
- Exercise-induced MTWA demonstrated high sensitivity (92%) and negative predictive value (99%) for predicting SCD post-myocardial infarction, suggesting its potential as a screening test.
- MTWA is also reported as useful for predicting SCD in patients with dilated cardiomyopathy (DCM) or impaired cardiac function.
Impact:
- MTWA can improve the selection of patients requiring further electrophysiologic evaluation and therapy for SCD prevention.
- This method may help optimize the use of interventions like ICDs by identifying high-risk individuals.
- Enhanced risk stratification using MTWA could lead to reduced incidence of sudden cardiac death in vulnerable patient populations.